Literature DB >> 29845376

Autoimmune hepatitis induced by a single injection of interferon-β 1a in a patient with multiple sclerosis.

Hiroki Yamaguchi1, Kenji Sakai2, Yoshinori Goto3, Masahito Yamada2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29845376     DOI： 10.1007/s00415-018-8912-x

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  11 in total

1.  Diagnosis and management of autoimmune hepatitis.

Authors:  Michael P Manns; Albert J Czaja; James D Gorham; Edward L Krawitt; Giorgina Mieli-Vergani; Diego Vergani; John M Vierling
Journal:  Hepatology       Date:  2010-06       Impact factor: 17.425

2.  Autoimmune hepatitis and multiple sclerosis: a coincidental association?

Authors:  J de Seze; V Canva-Delcambre; I Fajardy; S Delalande; T Stojkovic; E Godet; P Vermersch
Journal:  Mult Scler       Date:  2005-12       Impact factor: 6.312

3.  Development of autoimmune hepatitis type 1 after pulsed methylprednisolone therapy for multiple sclerosis: a case report.

Authors:  Atsushi Takahashi; Yukiko Kanno; Yuta Takahashi; Natsumi Sakamoto; Kyoko Monoe; Hironobu Saito; Kazumichi Abe; Junko Yokokawa; Atsushi Irisawa; Hiromasa Ohira
Journal:  World J Gastroenterol       Date:  2008-09-21       Impact factor: 5.742

Review 4.  Interferon beta 1a-induced severe autoimmune hepatitis in patients with multiple sclerosis: report of two cases and review of the literature.

Authors:  Alejandra Villamil; Eduardo Mullen; Paola Casciato; Adrian Gadano
Journal:  Ann Hepatol       Date:  2015 Mar-Apr       Impact factor: 2.400

5.  Autoimmune hepatitis-like reaction developing in a patient treated with interferon-β1a.

Authors:  Amrita Mishra; Maha Guindi; Gabor Kandel; Catherine J Streutker
Journal:  Histopathology       Date:  2014-08-06       Impact factor: 5.087

6.  Serum auto antibodies presence in multiple sclerosis patients treated with beta-interferon 1a and 1b.

Authors:  L Speciale; M Saresella; D Caputo; S Ruzzante; R Mancuso; M G Calvo; F R Guerini; P Ferrante
Journal:  J Neurovirol       Date:  2000-05       Impact factor: 2.643

7.  Drug induced liver injury secondary to interferon-beta (IFN-beta) in multiple sclerosis.

Authors:  V Byrnes; N Afdhal; T Challies; P E Greenstein
Journal:  Ann Hepatol       Date:  2006 Jan-Mar       Impact factor: 2.400

8.  A case of multiple sclerosis with atypical onset associated with autoimmune hepatitis and silent coeliac disease.

Authors:  Maria Teresa Ferrò; Diego Franciotta; Tommaso Riccardi; Elisabetta D'Adda; Elsa Mainardi; Alessandro Montanelli
Journal:  Neurol Sci       Date:  2008-04-01       Impact factor: 3.307

9.  Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.

Authors:  Chris H Polman; Stephen C Reingold; Brenda Banwell; Michel Clanet; Jeffrey A Cohen; Massimo Filippi; Kazuo Fujihara; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; Fred D Lublin; Xavier Montalban; Paul O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Emmanuelle Waubant; Brian Weinshenker; Jerry S Wolinsky
Journal:  Ann Neurol       Date:  2011-02       Impact factor: 10.422

10.  International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.

Authors:  Dean M Wingerchuk; Brenda Banwell; Jeffrey L Bennett; Philippe Cabre; William Carroll; Tanuja Chitnis; Jérôme de Seze; Kazuo Fujihara; Benjamin Greenberg; Anu Jacob; Sven Jarius; Marco Lana-Peixoto; Michael Levy; Jack H Simon; Silvia Tenembaum; Anthony L Traboulsee; Patrick Waters; Kay E Wellik; Brian G Weinshenker
Journal:  Neurology       Date:  2015-06-19       Impact factor: 9.910
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.